Comparative Effectiveness of Mycophenolate Mofetil for the Treatment of Juvenile‐Onset Proliferative Lupus Nephritis
- 2 November 2017
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 69 (12) , 1887-1894
Abstract
Objective: Although juvenile‐onset proliferative lupus nephritis (PLN) leads to significant morbidity and mortality, there is no clinical trials–based evidence to support the treatment effectiveness of any therapy for juvenile‐onset PLN. Marginal structural models enable us to estimate treatment effectiveness using observational data while accounting for confounding by indication.Methods: We used prospectively collected data to examine the effect of mycophenolate mofetil (MMF), compared to the use of other therapies, on the long‐term outcome of a juvenile‐onset PLN cohort (age at PLN onset <18 years). The major outcome variable was the estimated glomerular filtration rate (GFR) using the revised Schwartz formula. Confounding by indication was corrected for marginal structural model.Results: A total of 172 subjects with juvenile‐onset PLN, with a mean followup duration of approximately 4 years, were included. Overall, MMF was superior to other therapies, with a relative effect estimate for MMF of 1.06, i.e., 6% better estimated GFR on average (95% confidence interval 0.7, 11.3), corrected for potential confounding by indication. We found that beginning in year 4 there was a significant improvement in estimated GFR in the patients who were treated with MMF versus other therapies. This improvement was maintained until the end of the study.Conclusion: MMF was more beneficial than other therapies in improving/maintaining long‐term renal function in patients with juvenile‐onset PLN up to a maximum followup of 7 years. This finding is consistent with evidence from adult PLN clinical trials.Keywords
Funding Information
- University of Toronto
This publication has 36 references indexed in Scilit:
- Three Decades of Progress in Treating Childhood-Onset Lupus NephritisClinical Journal of the American Society of Nephrology, 2011
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialAnnals of the Rheumatic Diseases, 2010
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcomeRheumatology, 2008
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII)Lupus, 2008
- Impact of mis‐specification of the treatment model on estimates from a marginal structural modelStatistics in Medicine, 2008
- Analysis of Longitudinal Data with Irregular, Outcome-Dependent Follow-UpJournal of the Royal Statistical Society Series B: Statistical Methodology, 2004
- Retrospective analysis of the renal outcome of pediatric lupus nephritisClinical Rheumatology, 2004
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986